BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LY4175408 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LY4175408\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07046923-7738@assetmemo.bio
DTSTAMP:20261121T005442Z
DTSTART;VALUE=DATE:20300731
DTEND;VALUE=DATE:20300801
SUMMARY:LY4175408: Phase 1 readout est. (NCT07046923)
DESCRIPTION:LY4175408\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Stu
 dy of LY4175408 in Participants With Advanced Cancer\nEstimated primary co
 mpletion: July 2030. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 ly4175408#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT07046923
URL:https://assetmemo.bio/drug/ly4175408#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
